Notogen
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
661 University Ave Suite 13-1387, Toront...Phone Number
(647) 243-5278Website
www.notogen.comRevenue
<$5 MillionIndustry
About Notogen
Notogen is a preclinical biotechnology company focused on developing regenerative therapeutics for spinal pain and degeneration, specifically targeting degenerative disc disease. Their lead product, NTG-101, is a patented injectable treatment designed to protect spinal discs from degeneration and alleviate discogenic pain without the need for surgery. The company aims to provide a non-surgical, non-cellular solution that is commercially scalable and adheres to defined regulatory pathways. Notogen's innovative approach positions it to address the needs of patients suffering from back and neck dysfunction due to spinal disc degeneration.Explore more
Notogen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Notogen
Compare insights from companies similar to Notogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.2M
11-50
Private
$71.9M
2007
RW
Robert WynalekChief Operating Officer & Commercialization Chief & Officer
Notogen Tech Stack
A closer look at the technologies used by Notogen
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Notogen
Sign Up For FreeTo access detailed company insights
Notogen is a preclinical biotechnology company focused on developing regenerative therapeutics for spinal pain and degeneration, specifically targeting degenerative disc disease. Their lead product, NTG-101, is a patented injectable treatment designed to protect spinal discs from degeneration and alleviate discogenic pain without the need for surge... Read More
